Opko Health Investors Got Spooked Today, But Analyst Louise Chen Bets on Long-Term Sales Potential


Opko Health Inc. (NASDAQ:OPK) delivered a sore sight to the Street yesterday with a sharp third quarter miss in earnings that has sent investors scrambling away in the aftermath. However, Cantor analyst¬†Louise Chen¬†makes a confident case for the drug maker’s “underappreciated” earnings potential.

Story Continues